Cita APA

Schuler, M., Yang, J. C., Park, K., Kim, J., Bennouna, J., Chen, Y., . . . Planchard, D. (2016). Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: Phase III randomized LUX-Lung 5 trial. Ann Oncol.

Citación estilo Chicago

Schuler, M., et al. "Afatinib Beyond Progression in Patients With Non-small-cell Lung Cancer Following Chemotherapy, Erlotinib/gefitinib and Afatinib: Phase III Randomized LUX-Lung 5 Trial." Ann Oncol 2016.

Cita MLA

Schuler, M., et al. "Afatinib Beyond Progression in Patients With Non-small-cell Lung Cancer Following Chemotherapy, Erlotinib/gefitinib and Afatinib: Phase III Randomized LUX-Lung 5 Trial." Ann Oncol 2016.